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Abstract
Many adults suffering with knee pain due to osteoarthritis (OA) rely on 
intra-articular corticosteroids for pain management. Mesenchymal Stem 
Cells (MSC) intra-articular injections have emerged as an alternative 
treatment that may have less side effects and may alter disease 
progression. This review of literature seeks to compare efficacy of pain 
control of MSC injections compared to standard of care. More research 
is required however intra-articular MSC injections show statistically 
significant reductions in pain similar to corticosteroid injections.
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Overview:
● Chronic degenerative condition due to loss of articular cartilage
● Risk Factors: genetics, female sex, obesity, joint injury
● Pain, stiffness, loss of function → decreased mobility
● In the USA 30.8 million adults are affected by OA
○ by 2013 knee OA = $27 billion in annual health care 
expenditure
Treatments:
● first line: exercise, weight loss, NSAIDs
● intra-articular corticosteroid injections may be used for short term 
pain control
○ many patients eventually require knee arthroplasty
● MSC intra-articular injections are being investigated as alternative
○ may reduce pain and regenerate structure
Introduction
Methods
A literature search was conducted through PubMed, Clinical Key, and 
Google Scholar in October 2018 through April 2020. Eight articles 
consisting of randomized controlled trials were selected based on their 
relevance to research question, publication dates, interventions, and 
outcome measurements.
➢ Exclusion Criteria:
○ Systematic reviews or meta-analysis
○ Trials performed on animals
○ Trials performed on joints other than the knee
○ Studies investigating alternative interventions
○ Studies investigating conditions other than OA
● ACL tear, Rheumatoid Arthritis
Both MSC and Corticosteroids showed statistically significant 
improvements in pain in most of the studies, suggesting that MSCs 
may be as efficacious at controlling pain. 
Strengths:
● Corticosteroid sample sizes sufficient
● All RCT + adequate blinding → mitigation of bias/confounders
● Similar age ranges and KL grades
● Consistent corticosteroid dose across studies
● most studies use saline as placebo
● p value across studies was <0.05
● most studies utilized WOMAC and/or KOOS, pain rating scales
Limitations:
● MSC sample sizes too small
● inconsistency in dose and source of MSCs across studies
● inconsistent treatment regimen and follow up
● no direct comparison of corticosteroids and MSC injections
Future Research:
● Larger sample sizes of MSCs
● Determine optimal dosing and source of MSCs
● long term studies utilizing multiple injections, longer follow up
● direct comparison on MSC and corticosteroids
Discussion 
Table 1. Example Table  
Results 
Efficacy of Intra-articular Mesenchymal Stem Cell Injections Compared to 
Intra-articular Corticosteroids in Pain Control for Osteoarthritis of the Knee
The results of the study indicate that intra-articular MSC injections 
have the potential to become a widely utilized treatment for knee OA, 
similar to how corticosteroids are used today. An additional benefit is 
that they may reverse the disease process as seen by articular 
cartilage regeneration on MRI. More research is necessary.
At this time MSC injections may be an option for people with 
allergies to corticosteroids, or those with pain refractory to steroids. It 
also may be worth exploring for those who are not candidates for 
knee replacement surgery. Important factors to consider are 
availability and cost.
Overall this review shows that the novel treatment has merit, but in 
order to answer the question posed a direct comparison of MSC 
injections and corticosteroid injections in patients with knee OA is 
required.
Conclusion
Tble 2. Example Table
1. Emadedin M, Labibzadeh N, et al. (2018)
● RCT of 43 participants designed to compare single injection of autologous 
bone-marrow derived MSC to saline placebo to treat knee OA, follow up 
over 6 months
2. Song Y, Du H, Dai C, et al. (2018)
● RCT of 18 participants designed to compare low, mid range, and high doses 
of human adipose derived MSC for OA of the knee with two injections and 
long term follow up to 96 weeks
3. Vega A, Martin-Ferrero MA, Del Canto F, et al. (2015)
● RCT of 30 participants comparing allogeneic bone marrow MSC injection to 
hyaluronic acid (placebo) with injection on day 1 and follow up to 12 
months
4.Khalifeh SS, Forogh B, Ahmadbeigi N, et al. (2018)
● RCT of 20 participants designed to compare intra-articular injections of 
allogeneic placental MSCs with saline (placebo) with one injection and 
follow up to 24 weeks
5. Freitag J, Bates D, Wickham J, et al. (2019)
● RCT of 30 participants comparing autologous adipose derived MSC 
injections for knee OA with conservative treatment using two injections at 
day one and six months with follow up through 12 months
6.  McAlindon TE, LaValley MP, Harvey WF, et al. (2017)
● RCT of 140 participants designed to compare triamcinolone injection and 
placebo every 12 weeks for two years to evaluate pain and cartilage volume 
in patients with knee OA, follow up to 27 months
7. Bodick N, Lufkin J, Willwerth C, et al (2015)
● RCT of 228 participants comparing extended-release triamcinolone acetate 
with immediate release with injection on day 1 and follow up to 85 days
8. Shrestha R, Shrestha R, Thapa S, et al. (2018)
● RCT of 117 participants investigating intra-articular triamcinolone injections 
compared to saline (placebo) for knee OA in a community setting
 Study WOMAC KOOS Pain 
Rating
Quality 
of Life
Function
Tests
Cartilage 
change 
on MRI
1 (MSC) SS NA NS NA SS NA
2 (MSC) SS NA SS SS NA SS
3 (MSC) SS NA SS NS SS SS
4 (MSC) NA SS NS NA SS SS
5 (MSC) SS SS SS SS NA SS
6 (CS) NS NA NS NA NS SS
7 (CS) SS NA SS NA NA NA
8 (CS) SS SS SS NA NA NA
WOMAC = Western Ontario and McMaster Osteoarthritis Index; KOOS = knee osteoarthritis outcomes score; 
MSC = mesenchymal stem cells; CS = corticosteroids; SS = statistically significant; NS = not significant; NA = 
not applicable
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